The latest Investing Matters Podcast episode featuring Jeremy Skillington, CEO of Poolbeg Pharma has just been released. Listen here.
Not sure if SOHO will be much affected. I understand SOHO's tenants are mainly people with handicaps whose rent is paid by the Local Authorities, not by the tenants themselves. So no need for a price-cap for tenants of in this category, IMHO.
No need for the share price to go this low (around 100p today). SDG's wallpapers are bought by the financially better -off, these people will not opt for a cheapy wallpaper when decoration their home, they will look for a classy SDG-design.
I consider SDG relatively recession-safe. Share price ought to be in the range of 150p-180p. IMHO.
Looks to me that the accountants were not hapy at the fine of almost £10m being excluded from the
financial year, whether subject to appeal or not. IMHO, there should have been a provisional loss figure
in the books, as losing the case is a possibility.
Trading Update today is indeed positive, and yet the share price manages to fall.
Trading is in line, therefore EPS for this year in region of 10-12p can be expected.
Makes the shares look cheap. SDG operates in the luxury market, where wealthy
clients don't worry much about energy bills, or the cost of wallpaper.
If the Trading Update tomorrow is reasonably positive, then the share price is bound to rise...
Although, I must say, SDG is just about the only Company I know of, where the share price
mamages to fall on good news. The last RNS was positively good news, yet the share price
went down a bit.
BXP's share price on the Dhaka stock exchange is running pretty steady and stands today at Taka 153.20,
whaich translates into 135 pence GBP. The price-gap between Dhaka and here is currently ridiculously
wide. Narrowing the gap has to be on the cards, sooner or later.
Can anyone please explain why the selling of this stock continues even at below 125p whilst the dividend/fixed interest works out at 6.75% 'interest' at currnt price of 124p a share invested. Not a total defence against inflation, but goind a fair towards protecting capital.
A fast growing pharmaceutical Company on a PE-Ratio below 10! Surely that is cheap.
Shareholders on the Dhaka stock exchange apear to like the BXP shares, pay much more
per share. Difference is our shares here have no voting rights, that's all. Same dividend
rights though - I like that!
The shares can today be bought for just below 90p. That IMHO is excellent value. I topped up. Useful dividends from a
growing pharmaclleutical companay operating in recession-safe territory. I can not think of better value.
Cheers!